Clinical features of LRRK2 parkinsonism (Q34093433)

31 July 2017

1 reference

title

Clinical features of LRRK2 parkinsonism (English)

1 reference

31 July 2017

1 reference

parkinsonian syndrome

1 reference

2

Zbigniew K Wszolek

1 reference

31 July 2017

Kristoffer Haugarvoll

series ordinal

1

object named as

Kristoffer Haugarvoll

1 reference

31 July 2017

publication date

1 December 2009

1 reference

Parkinsonism and Related Disorders

31 July 2017

published in

1 reference

31 July 2017

volume

15 Suppl 3

1 reference

31 July 2017

page(s)

S205-8

1 reference

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Molecular pathogenesis of Parkinson disease: insights from genetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 R1628P increases risk of Parkinson's disease: replication evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Western Nebraska family (family D) with autosomal dominant parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Autosomal dominant parkinsonism associated with variable synuclein and tau pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 R1441G in Spanish patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

PARK8 LRRK2 parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Lrrk2 and Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Biochemical and pathological characterization of Lrrk2.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970815-6

7 January 2021

10.1016/S1353-8020(09)70815-6

Identifiers

DOI

1 reference

release_iayubn3eljdjpdpoenxdupgzty

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iayubn3eljdjpdpoenxdupgzty

24 November 2022

mapped directly with Wikidata item

1 reference